European Journal of General Medicine
Medical Investigations Society
Vol. 6, No. 3, 2009, pp. 187-188
Bioline Code: gm09040
Full paper language: English
Document type: Research Article
Document available free of charge
European Journal of General Medicine, Vol. 6, No. 3, 2009, pp. 187-188
© Copyright 2009 European Journal of General Medicine.
Primary breast lymphoma treated with R-CHOP chemotherapy|
Karagöz, Bülent; Bilgi, Oğuz; Erikçi, Alev Akyol; Özgun, Alpaslan; Türken, Orhan & Kandemir, Emin Gökhan
Primary breast lymphoma is rare disease which is treated with surgery, radiotherapy and chemoterapy. There is little experience of rituximab treatment is in breast lymphoma. Here we pres-ent a case of primary breast lymhoma treated with rituximab and chemotherapy combination. A 58-year-old woman referred for left breast mass. Radiologic imaging showed a mass of 4 cm in diameter. Pathologic examination of excisional biopsy specimen revealed Diffuse Large B Cell Lymphoma with CD20 positivity. The patient was stage IE (Ann Arbor). Mastectomy, lumpectomy or axil-lary dissection were not performed. Six courses of R-CHOP (CHOP plus rituximab) chemotherapy and radiotherapy were given. The complete response was obtained. The patient has been followed for 36 months with no evidence of disease recurrence. This is one of the first cases treated with rituximab. She has been followed for more than 36 months without relapse.
Breast lymphoma, rituximab, extranodal non-Hodgkin lymphoma
Alternative site location: http://www.ejgm.org